Exclusive

Exclusive Helen Branswell

STAT Plus: HHS leaves vacant more than half the slots on a key vaccine advisory panel

Exclusive Megan Molteni

Texas Medicaid agrees to fully cover gene therapy for Afghan refugees’ infant

Exclusive Mario Aguilar

STAT Plus: AI therapy and ICU training: A first look at health apps for Apple Vision Pro

Exclusive Jonathan Wosen

STAT Plus: Ultima Genomics launching high-end DNA sequencers that can read genome for $100

Exclusive Rachel Cohrs Zhang

STAT Plus: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension

Exclusive Jason Mast

STAT Plus: Dewpoint Therapeutics cuts 15% of staff, acknowledges Merck, Pfizer broke off partnerships over buzzy science

Exclusive Megan Molteni

STAT Plus: The Afghan father aided U.S. soldiers. Now Texas Medicaid won’t pay for his son’s gene therapy

Exclusive Allison DeAngelis

STAT Plus: Former Sage executives join biotech VC Cure Ventures

Exclusive Casey Ross

STAT Plus: Backed by Mayo Clinic and Microsoft, a nonprofit forms to test AI tools used in health care

Exclusive Matthew Herper

STAT Plus: Insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM

Exclusive Jason Mast

STAT Plus: Feng Zhang’s year-old CRISPR delivery startup Aera lays off quarter of staff

Exclusive Matthew Herper

STAT Plus: Amy Abernethy to step down as Verily’s chief medical officer in latest departure from company

Exclusive Annalisa Merelli

STAT Plus: Male birth control gets another shot with small new trial of non-hormonal pill

Exclusive Matthew Herper

STAT Plus: Sanofi says it has 12 blockbusters in its back pocket. Will investors believe it?

Exclusive Lev Facher and Rachel Cohrs Zhang

STAT Plus: Sweeping bill to fight opioid addiction will be considered by Senate health committee

Exclusive Theresa Gaffney

The push to get estrogen FDA-approved for gender-affirming care

Exclusive Matthew Herper

STAT Plus: CRISPR’s pioneers reflect on the first gene-editing treatment

Exclusive Sarah Owermohle

STAT Plus: FDA’s latest reorganization puts a new emphasis on its investigations

A STAT Investigation Casey Ross and Bob Herman

STAT Plus: UnitedHealth pushed employees to follow an algorithm to cut off Medicare patients’ rehab care

Exclusive Mario Aguilar

STAT Plus: Apple and Anthem’s experimental asthma app shows early promise but its future is uncertain

Exclusive Olivia Goldhill

Cancun abortion clinic aims to serve Americans from restrictive states

Exclusive Bob Herman and Casey Ross

STAT Plus: UnitedHealth discontinues a controversial brand amid scrutiny of algorithmic care denials

Exclusive Jason Mast

STAT Plus: Zuckerberg and Chan announce a New York biohub to build disease-fighting cellular machines

Exclusive Bob Herman

STAT Plus: In an unusual arrangement, UnitedHealth’s board chair also owns a personal investment firm

Exclusive Megan Molteni

STAT Plus: How one scientist’s determination made Novo Nordisk an obesity-drug powerhouse

Exclusive Jonathan Wosen

STAT Plus: Failed biotech gives a rare peek inside the tough breaks — and tough choices — that led to its demise

Exclusive Rachel Cohrs Zhang and John Wilkerson

STAT Plus: Key Senate panel eyes action on drug shortages

Exclusive Mario Aguilar and Matthew Herper

STAT Plus: Biogen shutters digital health group, nixes Apple study, as part of cost cuts

Exclusive Lev Facher

Markey and Manchin urge FDA to stop its study of opioids for chronic pain